Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers > Oncologists

Dr. Nina Shah, MD, Hematology Oncology | Myeloma

Accepting New Patients

(Dr. Nina Shah, MD)

(51 Ratings)

Specializes in: Oncology (Cancer Care), Hematology (Blood Disorders) and General Practice

New York University (NYU) School of Medicine

Professional interests include: myeloma

400 PARNASSUS AVENUE FLOOR 4
SAN FRANCISCO, CA 94143

(415) 353-2051

Dr. Nina Shah, MD, Hematology Oncology | Myeloma is an oncologist in SAN FRANCISCO, CA specializing in oncology (cancer care), hematology (blood disorders) and general practice. She graduated from New York University (NYU) School of Medicine. Dr. Nina Shah, MD, Hematology Oncology | Myeloma is affiliated with UCSF Health, UCSF, UCSF Medical Group, Hill Physicians and UCSF Hematology and Blood and Marrow Transplant.

Office Locations

400 PARNASSUS AVENUE FLOOR 4
SAN FRANCISCO, CA 94143

open_in_new

400 Parnassus Avenue Fourth Floor
San Francisco, CA 94143

open_in_new

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2012 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	242
hospital care	264
inpatient care	264

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2013 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	251
hospital care	229
inpatient care	229

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	78
Female	63

**Ethnicity**
Non-Hispanic White	87
Black	0
Hispanic	29
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	83
From 75 to 84	15
85 and over	0
Less than 65	43

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2013

Hypertension	74
High Cholesterol	54
Stroke	0
Ischemic Heart Disease	35
Depression	27
Chronic Kidney Disease	44
Asthma	0
Osteoperosis	19
Atrial Fibrilation	11
Heart Failure	26
Chronic Obstructive Pulmonary Disease	14
Diabetes	36
Dementia	0
Cancer	16

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2014 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	312
hospital care	305
inpatient care	305

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	79
Female	62

**Ethnicity**
Non-Hispanic White	88
Black	0
Hispanic	27
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	83
From 75 to 84	17
85 and over	0
Less than 65	41

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2014

Hypertension	75
High Cholesterol	56
Stroke	0
Ischemic Heart Disease	33
Depression	27
Chronic Kidney Disease	45
Asthma	0
Osteoperosis	18
Atrial Fibrilation	11
Heart Failure	23
Chronic Obstructive Pulmonary Disease	16
Diabetes	36
Dementia	0
Cancer	13

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2015 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	278
hospital care	292
inpatient care	292

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	170
Female	136

**Ethnicity**
Non-Hispanic White	214
Black	0
Hispanic	56
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	198
From 75 to 84	46
85 and over	0
Less than 65	62

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2015

Hypertension	73
High Cholesterol	54
Stroke	0
Ischemic Heart Disease	35
Depression	33
Chronic Kidney Disease	46
Asthma	8
Osteoperosis	14
Atrial Fibrilation	10
Heart Failure	18
Chronic Obstructive Pulmonary Disease	12
Diabetes	33
Dementia	0
Cancer	17

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2016 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	244
hospital care	211
inpatient care	211

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	90
Female	63

**Ethnicity**
Non-Hispanic White	99
Black	0
Hispanic	26
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	96
From 75 to 84	17
85 and over	0
Less than 65	40

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2016

Hypertension	70
High Cholesterol	50
Stroke	0
Ischemic Heart Disease	37
Depression	27
Chronic Kidney Disease	52
Asthma	13
Osteoperosis	8
Atrial Fibrilation	11
Heart Failure	23
Chronic Obstructive Pulmonary Disease	14
Diabetes	33
Dementia	10
Cancer	10

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2017 were hospital care, inpatient care, diagnostic procedures and bone marrow tests.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

bone marrow tests	21
diagnostic procedures	21
doctor visit	208
hospital care	150
inpatient care	150

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	79
Female	54

**Ethnicity**
Non-Hispanic White	92
Black	13
Hispanic	12
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	79
From 75 to 84	0
85 and over	0
Less than 65	31

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2017

Hypertension	58
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	31
Depression	27
Chronic Kidney Disease	47
Asthma	10
Osteoperosis	17
Atrial Fibrilation	0
Heart Failure	11
Chronic Obstructive Pulmonary Disease	8
Diabetes	24
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2018 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	265
hospital care	150
inpatient care	150

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	84
Female	75

**Ethnicity**
Non-Hispanic White	110
Black	0
Hispanic	14
Asian	16
Other	0
Native American	0

**Age**
From 65 to 74	97
From 75 to 84	34
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2018

Hypertension	58
High Cholesterol	35
Stroke	0
Ischemic Heart Disease	33
Depression	26
Chronic Kidney Disease	42
Asthma	0
Osteoperosis	13
Atrial Fibrilation	13
Heart Failure	18
Chronic Obstructive Pulmonary Disease	9
Diabetes	23
Dementia	0
Cancer	11

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2019 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	272
hospital care	82
inpatient care	82

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	73
Female	70

**Ethnicity**
Non-Hispanic White	84
Black	0
Hispanic	18
Asian	20
Other	0
Native American	0

**Age**
From 65 to 74	88
From 75 to 84	27
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2019

Hypertension	60
High Cholesterol	36
Stroke	0
Ischemic Heart Disease	27
Depression	22
Chronic Kidney Disease	50
Asthma	8
Osteoperosis	15
Atrial Fibrilation	10
Heart Failure	21
Chronic Obstructive Pulmonary Disease	12
Diabetes	25
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2020 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	375
hospital care	87
inpatient care	87

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	95
Female	90

**Ethnicity**
Non-Hispanic White	125
Black	0
Hispanic	13
Asian	26
Other	0
Native American	0

**Age**
From 65 to 74	112
From 75 to 84	36
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2020

Hypertension	59
High Cholesterol	41
Stroke	0
Ischemic Heart Disease	25
Depression	28
Chronic Kidney Disease	50
Asthma	7
Osteoperosis	9
Atrial Fibrilation	8
Heart Failure	20
Chronic Obstructive Pulmonary Disease	8
Diabetes	28
Dementia	6
Cancer	14

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2021 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	386
hospital care	134
inpatient care	134

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	108
Female	102

**Ethnicity**
Non-Hispanic White	155
Black	0
Hispanic	15
Asian	21
Other	0
Native American	0

**Age**
From 65 to 74	129
From 75 to 84	50
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2021

Hypertension	58
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	23
Depression	23
Chronic Kidney Disease	49
Asthma	10
Osteoperosis	11
Atrial Fibrilation	10
Heart Failure	18
Chronic Obstructive Pulmonary Disease	6
Diabetes	22
Dementia	5
Cancer	9

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA during 2022 were hospital care and inpatient care.

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

doctor visit	211
hospital care	94
inpatient care	94

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	90
Female	83

**Ethnicity**
Non-Hispanic White	122
Black	0
Hispanic	19
Asian	13
Other	0
Native American	0

**Age**
From 65 to 74	106
From 75 to 84	39
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma in 2022

Hypertension	63
High Cholesterol	50
Stroke	0
Ischemic Heart Disease	12
Depression	18
Chronic Kidney Disease	34
Asthma	10
Osteoperosis	17
Atrial Fibrilation	16
Heart Failure	15
Chronic Obstructive Pulmonary Disease	11
Diabetes	27
Dementia	0
Cancer	16

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Nina Shah, MD, Hematology Oncology | Myeloma for Medicare patients.

The highest averages for the top procedures that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated as an oncologist in SAN FRANCISCO, CA were hospital care, inpatient care, diagnostic procedures and bone marrow tests.

bone marrow tests	21
diagnostic procedures	21
doctor visit	276
hospital care	181
inpatient care	181

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma.

**Gender**
Male	86
Female	72

**Ethnicity**
Black / African American	1
Asian / Pacific Islander	8
Non-Hispanic White	106
Native American / Alaskan Native	0
Hispanic	20
Other	0

**Age**
75 to 84	25
85 and over	0
Less than 65	19
65 to 74	97

Average of Total of Conditions of Medicare patients treated by Dr. Nina Shah, MD, Hematology Oncology | Myeloma From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Nina Shah, MD, Hematology Oncology | Myeloma treated were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	58
High Cholesterol	40
Stroke	0
Ischemic Heart Disease	26
Depression	23
Chronic Kidney Disease	41
Asthma	6
Osteoporosis	12
Heart Failure	17
Chronic Obstructive Pulmonary Disease	10
Diabetes	26
Atrial Fibrillation	9
Dementia	1
Cancer	9

Education & Training

Dr. Nina Shah, MD, Hematology Oncology | Myeloma graduated from New York University (NYU) School of Medicine. She completed residency at New York-Presbyterian Hospital. She is certified by the American Board of Internal Medicine, Medical Oncology and has a state license in California.

Medical School: New York University (NYU) School of Medicine

Residency: New York-Presbyterian Hospital

Board Certification: American Board of Internal Medicine, Medical Oncology

Licensed In: California

Affiliations & Hospitals

Dr. Nina Shah, MD, Hematology Oncology | Myeloma is associated with these hospitals and organizations:

UCSF Health

UCSF

UCSF Medical Group

Hill Physicians

UCSF Hematology and Blood and Marrow Transplant

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Nina Shah, MD, Hematology Oncology | Myeloma appears to accept the following insurance providers: Cigna, Aetna, Blue Shield of California, Anthem, SCAN Health Plan, UnitedHealthcare, Health Net, Hill Physicians Care Solutions, Central Health Plan, CCHP Health Plan (Chinese Community Health Plan) and Canopy Health.

Insurance Accepted by Provider includes:

According to our sources, Dr. Nina Shah, MD, Hematology Oncology | Myeloma accepts the following insurance providers:

Cigna

Aetna

Blue Shield of California

Anthem

SCAN Health Plan

UnitedHealthcare

Health Net

Hill Physicians Care Solutions

Central Health Plan

CCHP Health Plan (Chinese Community Health Plan)

Canopy Health

Ratings & Reviews

Dr. Nina Shah, MD, Hematology Oncology | Myeloma has an exceptional overall rating with an average of 4.81 out of 5 stars based on 51 ratings. We collect ratings and reviews of Dr. Nina Shah, MD, Hematology Oncology | Myeloma from all over the web to help you find the right in SAN FRANCISCO, CA.

4.81

Overall Rating

(51 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Nina Shah, MD, Hematology Oncology | Myeloma. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
GENZYME CORPORATION	$61,096 SARCLISA $32,681	CD38 $12,002	MOZOBIL $8,762	NO PRODUCT DISCUSSED $4,055	LIBTAYO $2,157	Other $1,438
GlaxoSmithKline, LLC.	$37,468 BLENREP $7,150	$30,318
Karyopharm Therapeutics Inc.	$24,741 XPOVIO $24,741
AstraZeneca Pharmaceuticals LP	$23,290 $23,290
E.R. Squibb & Sons, L.L.C.	$21,646 EMPLICITI $12,863	OPDIVO $4,079	$4,703
Other	$74,548 Venclexta $12,624	Kyprolis $6,984	Privigen $6,482	MOZOBIL $3,575	NINLARO $3,368	Other $41,515

**Types of Payments**
Consulting Fee	$191,114
Honoraria	$13,949
Travel and Lodging	$10,999
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$10,177
Education	$7,875
Other	$8,675

Research Payments

Dr. Nina Shah, MD, Hematology Oncology | Myeloma has received 129 research payments totaling $5,192,110.

Biography

Dr. Nina Shah's medical specialty is general practice, oncology (cancer care), and hematology (blood disorders). The average patient rating for Dr. Shah is 5.0 stars (out of 5). Dr. Shah has indicated that her clinical interests include myeloma. She is affiliated with UCSF Medical Group and Hill Physicians. She appears to be an in-network provider for Blue Shield, Health Net, and Anthem, in addition to other insurance carriers. Dr. Shah's practice in SAN FRANCISCO, CA is open to new patients as reported by Doctor.com. Before completing her residency at New York-Presbyterian Hospital and a hospital affiliated with Columbia University, Dr. Shah attended medical school at New York University (NYU) School of Medicine.